The Division of AIDS (DAIDS) was formed in 1986 to develop and implement the national research agenda to address the HIV/AIDS epidemic. Toward that end, the Division supports a global research portfolio on HIV/AIDS, its related co-infections, and co-morbidities. With the ultimate goal of creating an “AIDS-free Generation,” the Division continually develops and supports the research infrastructure and scientific expertise needed to enable innovative approaches aimed at: 1) halting the spread of HIV through effective and acceptable prevention strategies and a preventive vaccine; 2) treating and curing HIV infection; 3) establishing treatment and prevention strategies for the HIV co-infections and co-morbidities of greatest significance; and 4) partnering with scientific and community stakeholders to implement effective interventions.
"Mississippi Baby" Now Has Detectable HIV, Researchers Find—July 10, 2014
Bulletin: HIV Vaccine Awareness Day—May 19, 2014
Bulletin: Regulatory Officials Informed of HVTN 503 HIV Vaccine Trial Findings—May 14, 2013
Media Availability: NIH Scientists Create New Tool for Identifying Powerful HIV Antibodies—May 9, 2013
Last Updated July 13, 2015